This is a historical report — it no longer reflects this drug's current status. Current status: Active Shortage. View this drug's full profile page →
MONOPROST
LABORATOIRES THEA
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MONOPROST in Canada?
Yes. MONOPROST 50MCG has an active shortage reported to Health Canada (last updated October 16, 2026).
Why is MONOPROST not available?
The reason the manufacturer reported: Delay in shipping of the drug.
When will MONOPROST be available again?
The manufacturer's estimated resolution date is December 15, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Glaucoma Eye Drop Shortage in Canada: Latanoprost, Timolol Combinations, and More
Why glaucoma drops like latanoprost and dorzolamide/timolol show up in shortage reports often, why you shouldn't stop using them, and what to do instead.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02456230
Strength
50MCG
Dosage Form
SOLUTION
Route
OPHTHALMIC
Active Ingredient
LATANOPROST
Tier
Unrated
Last Updated
2026-07-16
Reason for Shortage
Delay in shipping of the drug.
Past Reports for This Drug
MONOPROST has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from LABORATOIRES THEA
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.